|CIRM chart showing jump in clinical trials at institutions|
currently in the Alpha Clinic Network
Last week California's soon-to-be $40 million Alpha stem cell clinic network drew attention from within the stem cell community but little notice in the media.
A symposium last Thursday at the City of Hope on the effort covered aspects of the effort ranging from its results to what patients had to say. As of this morning, only one story had surfaced.
Claudia Palma of the Pasadena Star-News wrote a piece that sketched out something of an overview, including quotes from John Zaia, the principal investigator for the Alpha clinic at the City of Hope. Other clinics are in place at UC San Diego and UCLA/UC Irvine.
The $3 billion, California stem cell agency initiated the program in 2014 and plans to add two more sites this year.
Capitol Weekly, an online news service focusing on state government, picked up the article from the symposium by the California Stem Cell Report on an effort to keep the agency going after it runs out of money in 2020.
Stem cell agency officials also appeared at the conference, including Geoff Lomax, senior officer for strategic initiatives, who laid out the Alpha Clinic program. His presentation highlighted the boost in number of stem cell trials at the three institutions plus
|CIRM graphic on Alpha trials and range of afflictions|